Titan America SA Common Shares (TTAM)
15.36
+0.44 (2.95%)
NYSE · Last Trade: Oct 9th, 1:43 AM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025